NAV
$34.21
AUM
$6.1B
Expense Ratio
-
Dividend Yield
0.00%
Beta
0.90
Currency
USD
| YTD | 1M | 3M | 1Y | 3Y | 5Y |
|---|---|---|---|---|---|
| +8.86% | +2.83% | +5.54% | +17.85% | +14.28% | - |
| # | Symbol | Name | Weight |
|---|---|---|---|
| 1 | ASML | ASML Holding NV ADR | 3.57% |
| 2 | ROP.SW | Roche Holding AG Ordinary Shares new | 3.01% |
| 3 | NESN.SW | Nestle SA | 2.13% |
| 4 | BHP.AX | BHP Group Ltd | 1.71% |
| 5 | 6758.T | Sony Group Corp | 1.56% |
| 6 | NVS | Novartis AG ADR | 1.40% |
| 7 | AZN.L | AstraZeneca PLC | 1.35% |
| 8 | MC.PA | Lvmh Moet Hennessy Louis Vuitton SE | 1.34% |
| 9 | 8035.T | Tokyo Electron Ltd | 1.26% |
| 10 | IFX.DE | Infineon Technologies AG | 1.14% |
The Portfolio is designed to purchase securities of large non-U.S. companies that the Advisor determines to have high profitability relative to other large capitalization companies in the same country or region, at the time of purchase. The Portfolio may emphasize certain stocks, including smaller capitalization companies, lower relative price stocks, and/or higher profitability stocks as compared to their representation in the large-cap high profitability segments of developed non-U.S. markets.
Inception Date: 2022-03-23